News

Peramivir is in clinical development for the treatment of seasonal and potentially life-threatening human influenza. Two different doses of peramivir will be tested. “The safety and antiviral activity

The Universite de Montreal evaluated the short-term effectiveness and tolerability of two depression treatments in patients with coronary artery disease (CAD); citalopram, a selective serotonin reuptake inhibitor (SSRI)

“Relamine can help reduce the swelling in the joints, control joint pain associated with osteoarthritis, reduce the onset and progression of osteoarthritis and can be used in combination

In September 2005, Innogenetics sued Abbott alleging the company was infringing its patent which covers a method of genotyping the hepatitis C virus. The jury's decision supported Innogenetics'

High-risk patients who develop invasive fungal infections (IFIs) have a mortality rate ranging from 50-90%. In both these studies Noxafil, also known as posaconazole, was significantly more effective

Pfizer lost patient protection on Zoloft last year. Zoloft is a drug designed to treat patients with depression and anxiety. Teva filed the complaints in the US District

<p>Barr filed an abbreviated new drug application for a generic version of Thalomid 200mg capsules with the FDA in September 2006, claiming that the patents protecting Thalomid from

British Scientists will develop robotics to automate important stem cell research, meaning thousands of experiments will be able to be conducted at once, rather than just a handful

The study shows that the combination of INGN 241 and Avastin is very effective and blocks tumor angiogenesis, the formation of new blood vessels within a tumor that